FDA Inspection 910949 — ImpactLife

ImpactLife — FEI 1470264

The FDA completed an inspection of ImpactLife on January 22, 2015 in Moline, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 22, 2015
Fiscal Year
2015
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Moline, IL (United States)